Aim To identify short-term effects of extracorporeal shock wave lithotripsy (ESWL) on renal function in children and adolescents with single kidney stones. Methods In a 4-year period 30 children (15 boys and 15 girls) from 10 to 18 years of age were treated for unilateral renal stones with ESWL. Inclusion criteria were: up to 18 years of age, kidney stone (from 4 to 20 mm in diameter) visible on X-ray, first ESWL treatment, unilateral lithotripsy treatment without previous kidney surgery, patients without infravesical obstruction, patients without proven urinary infection, repeated use of one (the same) analgesic, patients without anticoagulant and antihypertensive therapy, patients without use of nephrotoxic drugs prior to and during the treatment, normal blood pressure, non-pregnancy patients with normal renal function. Serum enzymes (alkaline phosphatase, lactate dehydrogenase), cystatin C, serum and urine electrolytes (sodium, potassium, chloride), and urine neutrophil gelatinase-associated lipocalin (uNGAL) were tested before, on the first and fifth day after the treatment. Results An increase of alkaline phosphatase and lactate dehydrogenase was statistically significant on day 1 (p<0.05) and values returned to normal on day 5. Serum cystatin C level was also significantly increased during the first four days after ESWL treatment (p<0.05) and returned to baseline on post-treatment day 5. There was a statistically significant difference in the level of uNGAL in urine before and 24 hours after ESWL treatment (p<0.05). Conclusion The ESWL is a safe and curative procedure for the treatment of kidney stones in children and adolescents with no evidence of serious adverse effects on renal function.
Jobs K, Straż-Żebrowska E, Placzyńska M, Zdanowski R, Kalicki B, Lewicki S, et al. Interleukin18 and NGAL in assessment of ESWL treatment safety in children with urolithiasis. Cent Eur J Immunol. 2014. p. 384–91.
2.
Iguchi M, Umekawa T, Katoh Y, Kohri K, Kurita T. Prevalence of urolithiasis In Kaizuka city, Japanes epidemiologic study of urinary stones. Int J Urol. 1996. p. 175–9.
3.
Miliner D, Murphy M. Urolithiasis in pediatric patients. Mayo Clin Proceed. 1993. p. 241–8.
4.
Bichler K, Lahme S, Strohmaier W. Indications for open stone removal of urinary calculi. Urol Int. 1997. p. 102–8.
5.
Paik M, Resnick M. Is there a role for open stone surgery? Urol Clin North Am. 2000. p. 323–31.
6.
Honeck P, Wendt-Nordahl G, Krombach P, Bach T, Häcker A, Alken P, et al. Does open stone surgery still play a role in the treatment of urolithiasis? Data of a primary urolithiasis centre. J Endourol. 2009. p. 1209–12.
7.
Jee J, Kim S, Cho W. Efficacy of extracorporeal shock wave lithotripsy in pediatric and adolescent urolithiasis. Korean J Urol. 2013. p. 865–9.
8.
Tan M, Kirac M, Onaran M, Karaoglan U, Deniz N, Bozkirli I. Factors affecting the success rate of extracorporeal shock wave lithotripsy for renal calculi in children. Urol Res. 2006. p. 215–21.
9.
Aksoy Y, Ozbey I, Atmaca A, Polat O. Extracorporeal shock wave lithotripsy in children: experience using a mpl-9000 lithotriptor. World J Urol. 2004. p. 115–9.
10.
Demirkesen O, Onal B, Altintas R, Altintaş R, Yalçin V, Oner A. Efficacy of extracorporeal shock wave lithotripsy for isolated lower caliceal stones in children compared with stones in other renal locations. Urology. 2006. p. 170–4.
11.
Cohen T, Ehreth J, King L, Preminger G. Pediatric urolithiasis: medical and surgical management. Urology. 1996. p. 292–303.
12.
Aksoy Y, Yapanoğlu T, Özbey I. TheeEfficacy and safety of extracorporeal shock wave lithotripsy in children. Eurasian J Med. 2009. p. 120–5.
13.
Evan A, Willis L, Connors B, Reed G, Mcateer J, Lingeman J. Shock wave lithotripsy-induced renal injury. Am J Kidney Dis. 1991. p. 445–50.
14.
Dhar N, Thornton J, Karafa M, Streem S. A multivariate analysis of risk factors associated with subcapsular hematoma formation following electromagnetic shock wave lithotripsy. J Urol. 2004. p. 2271–4.
15.
Thomas R, Frentz J, Harmon E, Frentz G. Effects of extracorporeal shock wave lithotripsy on renal growth and body height in pediatric patients. J Urol. 1992. p. 1064–6.
16.
Lottmann H, Archambaud F, Traxer O, Mercier-Pageyral B, Helal B. The efficacy and parenchymal consequences of extracorporeal shock wave lithotripsy in infants. BJU Int. 2000. p. 311–5.
17.
D’addessi A, Bongiovanni L, Racioppi M, Sacco E, Bassi P. Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? J Pediatr Surg. 2008. p. 591–6.
18.
Cruz D, Goh C, Palazzuoli A, Slavin L, Calabrò A, Ronco C, et al. Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes. Heart Fail Rev. 2011. p. 545–51.
19.
Bellomo R, Kellum J, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med. 2004. p. 33–7.
20.
Karlsen S, Berg K. Acute changes in kidney function following extracorporeal shock wave lithotripsy for renal stones. Br J Urol. 1991. p. 241–5.
21.
Villányi K, Székely J, Farkas L, Jávor E, Pusztai C. Short term changes in renal function after extracorporeal shock wave lithotripsy in children. J Urol. 2001. p. 222–4.
22.
Shakir M, Karira K, Rani M, Shaikh H. Effects of extracorporeal shockwave lithotripsy (ESWL) on ezymatic and electrolytic levels in renal stone patients. Med Channel. 2010. p. 206–10.
23.
Ronco C, Mccullough P, Anker S, Anand I, Aspromonte N, Bagshaw S, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010. p. 703–11.
24.
Nguyen M, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatrc Nephrol. 2008. p. 2151–7.
25.
Siew E, Ware L, Gebretsadik T, Shintani A, Moons K, Wickersham N, et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. JASN. 2009. p. 1823–32.
26.
Bagshaw S, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus nonseptic acute kidney injury in critical illness. ICM. 2010. p. 452–61.
27.
Makris K, Markou N, Evodia E, Dimopoulou E, Drakopoulos I, Ntetsika K, et al. Urinary neutrophil gelatinaseassociated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. CCLM. 2009. p. 79–82.
28.
Schinstock C, Semret M, Wagner S, Borland T, Bryant S, Kashani K, et al. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury. Nephrol Dial Transplant. 2013. p. 1175–85.
29.
Grenier F, Ali S, Syed H, Workman R, Martens F, Liao M, et al. Evaluation of the AR-CHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem. 2010. p. 615–20.
30.
Fahmy N, Sener A, Sabbisetti V, Nott L, Lang R, Welk B, et al. Urinary expression of novel tissue markers of kidney injury after ureteroscopy, shockwavelithotripsy, and in normal healthy controls. J Endourol. 2013. p. 1455–62.
31.
Vittori M, Baroni S, Ferraro P, Gambaro G, Morelli R, Bassi P, et al. Neutrophil gelatinaseassociated lipocalin (NGAL) value changes before and after shock wave lithotripsy. Urolithiasis. 2017. p. 347–51.
32.
Kardakos I, Volanis D, Kalikaki A, Tzortzis V, Serafetinides E, Melekos M, et al. Evaluation of neutrophil gelatinase-associated lipocalin,interleukin-18, and cystatin C as molecular markers before and after unilateral shock wave lithotripsy. Urology. 2014. p. 783–8.
33.
Randers E, Erlandsen E. Serum cystatin C as an endogenous marker of the renal function-a review. Clin Chem Lab Med. 1999. p. 389–95.
34.
Stevens L, Schmid C, Greene T, Li L, Beck G, Joffe M, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009. p. 652–60.
35.
Salah M, Béla T, Antal F, Gyorgi T, Nagy-Ujlaky L, Toth C. Measurement of serum cystatin C as a new marker of glomerular filtration rate after extracorporeal shock wave lithotripsy. Magyar Urologia. 2005. p. 122–6.
36.
Nomikos M, Kardakos I, Kalikaki A, Karyotis E, Serafedinides V, Tzortzis I, et al. Interleukin-18 and N-GAL levels as biomarkers of inflammatory response after extracorporeal shock wave lithotripsy. Urology. 2011. p. 107–8.
37.
Shakir M, Karira K, Rani. Evaluation of renal damage related to different energy levels of shockwaves after extracorporeal shockwave lithotripsy (ESWL). Med Chanel. 2016. p. 70–7.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
